Drey Michael, Otto Sven, Thomasius Friederike, Schmidmaier Ralf
Medizinische Klinik IV, Schwerpunkt Geriatrie, LMU Klinikum München, Ziemssenstraße 5, 80336, München, Deutschland.
Klinik und Poliklinik für Mund-Kiefer-Gesichtschirurgie, LMU Klinikum München, München, Deutschland.
Z Gerontol Geriatr. 2023 Nov;56(7):597-605. doi: 10.1007/s00391-023-02245-5. Epub 2023 Oct 16.
With the aid of a new fracture risk model, the great treatment gap for osteoporosis should be closed. All patients older than 70 years should undergo a diagnostic procedure for osteoporosis. An additional risk threshold (≥ 10% per 3 years for femoral and vertebral fractures) should enable patients with a high risk of fracture to be treated with osteoanabolic agents. The use of osteoanabolic agents makes it necessary to administer antiresorptive drugs afterwards. Due to the low event rate of osteonecrosis of the jaw, the initiation of a specific osteoporosis treatment should not be delayed by prophylactic dental treatment. The adherence to the drug treatment should be improved by an individualized approach on the basis of a cooperation between patients, caregivers, and physicians. A regular assessment of falls, including the timed up and go test should be carried out in patients older than 70 years.
借助一种新的骨折风险模型,骨质疏松症巨大的治疗差距应能得到弥合。所有70岁以上患者均应接受骨质疏松症诊断程序。一个额外的风险阈值(股骨和椎体骨折每3年≥10%)应能使骨折高风险患者接受骨合成代谢药物治疗。使用骨合成代谢药物后有必要给予抗吸收药物。由于颌骨坏死的发生率较低,不应因预防性牙科治疗而延迟启动特定的骨质疏松症治疗。应通过患者、护理人员和医生之间合作的个体化方法来提高药物治疗的依从性。应对70岁以上患者定期进行跌倒评估,包括计时起立行走测试。